跳至主要内容
临床试验/NCT01260558
NCT01260558Unknown4 期

Pilop Trial of OCT-determined Coverage of Permanent or Polymer-free Sirolimus Eluting Stent at Long Term

Deutsches Herzzentrum Muenchen4 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2010年12月1日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
20
试验地点
4
主要终点
Degree of stent strut coverage after 5 years assessed by OCT for each visible strut segment

研究概览

简要总结

The objective of this pilot study is to compare the PFS-eluting stent (ISAR Rapa G1) with the PPS-eluting stent (Cypher®) regarding uncovered stent strut segments at 5 years.

详细描述

The mid-term efficacy of drug-eluting stents has been well-established, but there is an ongoing debate on the potential of an increased incidence of late stent thrombosis, particularly after discontinuation of thienopyridine therapy, as well as of delayed onset of restenosis or catch-up phenomenon with permanent polymer-based DES. The extent of strut coverage with reduction of exposed thrombogenic material has been shown to be associated with the inflammatory reaction grade and with the incidence of stent thrombosis. The optical coherence tomography (OCT) is an intravascular imaging modality based on light. The principle is similar to intravascular ultrasound, but due to the much shorter wave length of light, it offers a much better resolution up to 10µm, enabling the exact determination of strut coverage, neointimal thickness, vessel size, presence of dissections, and even the presence of inflammation.

Patients who received a polymer-free or a permanent-polymer sirolimus-eluting stent about 5 years ago without in-segment intervention since, will be evaluated by OCT regarding the healing pattern and the late lumen loss of the stent.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than age 18 with with previous implantation of polymer-free or permanent-polymer sirolimus-eluting stents 5 years ago due to ischemic symptoms or evidence of myocardial ischemia in the presence of ≥ 50% stenosis located in native coronary vessels.
  • Written, informed consent by the patient or her/his legally-authorized representative for participation in the study and assessment by OCT.
  • In women with childbearing potential a negative pregnancy test is mandatory.

排除标准

  • Intervention in the segment of the study stent after the index procedure
  • Target lesion located in the left main trunk.
  • In-stent restenosis with difficulty to pass the OCT device
  • Acute myocardial infarction
  • Known allergy to the study medications: Sirolimus, rapamycin, probucol or stainless steel.
  • Pregnancy (present, suspected or planned) or positive pregnancy test.
  • Patient's inability to fully cooperate with the study protocol.

结局指标

主要结局

Degree of stent strut coverage after 5 years assessed by OCT for each visible strut segment

时间窗: 5 years

次要结局

  • Percentage of malapposed strut assessed by OCT(5 years)
  • Percentage of uncovered malapposed struts assessed by OCT(5 years)
  • Morphologic differences of neointima between stents(5 years)
  • Late lumen loss at 5 years assessed by OCT(5 years)

研究者

发起方
Deutsches Herzzentrum Muenchen
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验